Glassman Wealth Services’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-28
Closed 2045
2022
Q3
$0 Hold
28
﹤0.01% 2002
2022
Q2
$1K Hold
28
﹤0.01% 1558
2022
Q1
$1K Sell
28
-84
-75% -$2.4K ﹤0.01% 1544
2021
Q4
$5K Hold
112
﹤0.01% 1007
2021
Q3
$5K Hold
112
﹤0.01% 990
2021
Q2
$4K Sell
112
-2
-2% -$86 ﹤0.01% 1010
2021
Q1
$6K Buy
114
+2
+2% +$115 ﹤0.01% 836
2020
Q4
$5K Buy
+112
New +$5.19K ﹤0.01% 882
2019
Q3
Sell
-19
Closed -$1K 1384
2019
Q2
$1K Buy
19
+7
+58% +$175 ﹤0.01% 950
2019
Q1
$0 Buy
+12
New +$229 ﹤0.01% 1215

Other funds holding VCYT

Glassman Wealth Services's VCYT Position: Q4 2022 in Review

Glassman Wealth Services sold out of Veracyte (VCYT) in Q4 2022, closing a stake of 28 shares.

Glassman Wealth Services first reported a position in VCYT in Q1 2019 and held it in 10 quarters. The position peaked at $6K in Q1 2021. 223 funds tracked by Wall St. Rank hold VCYT as of Q4 2022.

  • Glassman Wealth Services reported no remaining Veracyte position as of Q4 2022 after selling out during the quarter.
  • Glassman Wealth Services sold 28 Veracyte shares in Q4 2022.
  • Glassman Wealth Services first reported a position in Veracyte in Q1 2019 and held it in 10 quarters.
  • Glassman Wealth Services's Veracyte position peaked at $6K in Q1 2021.
  • 223 funds tracked by Wall St. Rank held Veracyte as of Q4 2022.

Based on Glassman Wealth Services's 13F filing for Q4 2022, filed 6 Feb 2023.